Sharp Fluidics Clinical Study, Efficacy of a Novel Intraoperative Engineered Sharps Injury Prevention Device: Pilot Usability and Efficacy Trial, Published in JMIR Perioperative Medicine

December 22, 2020

Sharp Fluidics reports the first prospective, case-controlled clinical study of an Engineered Sharps Injury Prevention (ESIP) device to prevent Needle Stick Injuries (NSI) in an operating room demonstrated that the use of Operative Armour®, a wearable needle safety and workflow efficiency device, reduces surgical needle passes and handling during surgical closure.

This study, “Efficacy of a Novel Intraoperative Engineered Sharps Injury Prevention Device: Pilot Usability and Efficacy Trial,” Jenny Hillary, M.D., et al. conducted at The Johns Hopkins University School of Medicine, was published in JMIR Perioperative Medicine.

In the 100-patient study, 50 procedures were performed using Operative Armour and 50 control procedures without.  The procedures performed were in Plastics Surgery including abdominal surgery, breast reconstruction, and mastopexy/breast reduction or revisions.  During these procedures, Operative Armour resulted in as many as half the needle adjustments by hand.

“In this study at Johns Hopkins it was found that Operative Armour functions effectively as an engineered Sharps Injury Prevention device by decreasing intraoperative needle passing and handling”, said Douglas Rimer, President of Sharp Fluidics.  “The authors stated, ‘By minimizing sharps behaviors that drive needle stick injuries such as manipulation, handling, and passing of intraoperative sharps, Operative Armour demonstrates superiority over the current practice in the potential to significantly decrease sharp injuries.  We anticipate an associated decrease in needlestick injuries with the use of the device.'”

Other observations by the authors included the potential for OR efficiency gains, “In addition to the device’s impact on needlestick risk, it may also have the potential to improve efficiency by introducing parallel processing in which two or more separate processes are conducted simultaneously rather than in series.” While the surgeon is closing independently, managing their own sutures, the circulator and scrub-tech can focus on performing their final count and breaking down the room, eliminating conflict between these two equally important activities.

The study concluded that Operative Armour effectively functions as an ESIP device by decreasing intraoperative needle passing and handling.  With over 88,000 operating room needlestick injuries in the US each year, Operative Armour provides a new option to help keep Surgeons, Nurses, and other medical staff safer in the operating room.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The ArthroFree system is the first FDA-cleared wireless camera for arthroscopy and general endoscopy, both areas of minimally invasive surgery. The system is designed to help surgeons work with aximum dexterity and focus.
The project, which was led by the University of Southern California, included large increases in representation among men of African, Hispanic and Asian ancestries, that were contributed in part by an ongoing collaboration between the U.S. Department of Veterans Affairs and DOE reports Argonne.
This innovative software turns smartphones into medical-grade stethoscopes, allowing people to capture, analyze, and share critical heart health data with medical personnel from the comfort of any location notes Sparrow BioAcoustics.
"Taewoong Medical becoming an Olympus group company is also a major milestone in our global growth strategy," said Henry Shin, CEO of STARmed. "We look forward to our products being made available to more patients through Olympus' global distribution network."
The company reports they have successfully met the six-month primary endpoint for the first-ever female patient implanted with the UroActive™ System, the first smart automated artificial urinary sphincter (AUS) to treat SUI.

By using this website you agree to accept Medical Device News Magazine Privacy Policy